TFF Pharmaceuticals (TFFP) Competitors $0.06 0.00 (0.00%) As of 03/28/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TFFP vs. TRVN, PTEIQ, NMTR, EVFM, TNFA, VIRX, MYMD, AEON, PTPI, and ATXIShould you be buying TFF Pharmaceuticals stock or one of its competitors? The main competitors of TFF Pharmaceuticals include Trevena (TRVN), PolarityTE (PTEIQ), 9 Meters Biopharma (NMTR), Evofem Biosciences (EVFM), TNF Pharmaceuticals (TNFA), Viracta Therapeutics (VIRX), MyMD Pharmaceuticals (MYMD), AEON Biopharma (AEON), Petros Pharmaceuticals (PTPI), and Avenue Therapeutics (ATXI). These companies are all part of the "pharmaceutical products" industry. TFF Pharmaceuticals vs. Trevena PolarityTE 9 Meters Biopharma Evofem Biosciences TNF Pharmaceuticals Viracta Therapeutics MyMD Pharmaceuticals AEON Biopharma Petros Pharmaceuticals Avenue Therapeutics Trevena (NASDAQ:TRVN) and TFF Pharmaceuticals (NASDAQ:TFFP) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, community ranking, valuation and profitability. Which has stronger earnings & valuation, TRVN or TFFP? TFF Pharmaceuticals has lower revenue, but higher earnings than Trevena. Trevena is trading at a lower price-to-earnings ratio than TFF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTrevena$443K2.44-$40.29M-$47.04-0.03TFF Pharmaceuticals-$70.98K-4.07-$21.24M-$6.44-0.01 Does the MarketBeat Community believe in TRVN or TFFP? Trevena received 549 more outperform votes than TFF Pharmaceuticals when rated by MarketBeat users. Likewise, 68.75% of users gave Trevena an outperform vote while only 67.68% of users gave TFF Pharmaceuticals an outperform vote. CompanyUnderperformOutperformTrevenaOutperform Votes61668.75% Underperform Votes28031.25% TFF PharmaceuticalsOutperform Votes6767.68% Underperform Votes3232.32% Does the media prefer TRVN or TFFP? In the previous week, Trevena had 1 more articles in the media than TFF Pharmaceuticals. MarketBeat recorded 1 mentions for Trevena and 0 mentions for TFF Pharmaceuticals. Trevena's average media sentiment score of 0.00 equaled TFF Pharmaceuticals'average media sentiment score. Company Overall Sentiment Trevena Neutral TFF Pharmaceuticals Neutral Which has more volatility & risk, TRVN or TFFP? Trevena has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, TFF Pharmaceuticals has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Do analysts recommend TRVN or TFFP? Trevena presently has a consensus target price of $5.00, suggesting a potential upside of 300.00%. Given Trevena's stronger consensus rating and higher probable upside, analysts plainly believe Trevena is more favorable than TFF Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Trevena 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00TFF Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is TRVN or TFFP more profitable? Trevena has a net margin of 0.00% compared to TFF Pharmaceuticals' net margin of -1,596.64%. Trevena's return on equity of 0.00% beat TFF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets TrevenaN/A N/A -119.55% TFF Pharmaceuticals -1,596.64%-310.17%-196.06% Do insiders and institutionals hold more shares of TRVN or TFFP? 13.6% of Trevena shares are owned by institutional investors. Comparatively, 15.3% of TFF Pharmaceuticals shares are owned by institutional investors. 2.7% of Trevena shares are owned by company insiders. Comparatively, 4.5% of TFF Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryTrevena beats TFF Pharmaceuticals on 10 of the 16 factors compared between the two stocks. Remove Ads Get TFF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TFFP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TFFP vs. The Competition Export to ExcelMetricTFF PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$289,000.00$6.90B$5.63B$7.84BDividend YieldN/A2.76%5.33%4.01%P/E Ratio-0.017.2623.5518.73Price / Sales-4.07218.61388.1990.75Price / CashN/A65.6738.1734.64Price / Book0.026.386.894.23Net Income-$21.24M$142.34M$3.20B$247.47M7 Day PerformanceN/A-5.15%-3.06%-2.29%1 Month PerformanceN/A-7.55%1.51%-5.81%1 Year PerformanceN/A-11.06%9.37%-0.96% TFF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TFFPTFF PharmaceuticalsN/A$0.07flatN/AN/A$289,000.00$-70,983.00-0.0119TRVNTrevena0.8103 of 5 stars$1.28-3.0%$5.00+290.6%-89.1%$1.11M$443,000.00-0.0340Analyst ForecastNews CoveragePTEIQPolarityTEN/A$0.15flatN/A+50.3%$1.10M$810,000.00-0.0560NMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A-0.0220EVFMEvofem Biosciences0.4967 of 5 stars$0.01-11.0%N/A-59.3%$1.01M$11.39M-0.01120News CoverageGap DownTNFATNF PharmaceuticalsN/A$0.36-4.2%N/AN/A$995,000.00N/A0.006Gap DownVIRXViracta Therapeutics1.1519 of 5 stars$0.02-8.4%$4.05+17,585.6%-97.5%$910,000.00N/A-0.0220MYMDMyMD PharmaceuticalsN/A$0.38+3.4%N/A-84.9%$893,000.00N/A0.006Gap DownAEONAEON Biopharma1.7297 of 5 stars$0.72+8.0%$360.00+49,637.5%-99.9%$805,000.00N/A4.025Upcoming EarningsNews CoverageGap DownPTPIPetros Pharmaceuticals0.3808 of 5 stars$0.07-2.7%N/A-94.2%$804,000.00$4.02M-0.0120Short Interest ↑Gap DownHigh Trading VolumeATXIAvenue Therapeutics2.9261 of 5 stars$0.36-0.6%N/A-97.2%$739,000.00N/A0.024 Remove Ads Related Companies and Tools Related Companies Trevena Competitors PolarityTE Competitors 9 Meters Biopharma Competitors Evofem Biosciences Competitors TNF Pharmaceuticals Competitors Viracta Therapeutics Competitors MyMD Pharmaceuticals Competitors AEON Biopharma Competitors Petros Pharmaceuticals Competitors Avenue Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TFFP) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TFF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TFF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.